Navigation Links
Review of cervical cancer screening program shows effectiveness and room for improvement
Date:4/29/2008

Women who do not undergo regular cervical cancer screening tests are more likely to be diagnosed with the disease than those who do, according to an audit of the Swedish national cervical cancer screening program that will be published online April 29 in the Journal of the National Cancer Institute. Participation in screening reduces the risk for all types of cervical cancers in all ages. Better follow-up of the women who are screened could further reduce cervical cancer rates, the researchers concluded.

Cervical cancer screening programs reduce the incidence of disease, but the effectiveness of such programs varies among populations. Regular audits of screening programs are valuable because they provide insight into how a program works and how it might be improved.

In this nationwide case–control study, Bengt Andrae, M.D., and colleagues of the Gävle Hospital and the Karolinska Institute in Sweden compared the rates of cervical cancer diagnosis in women who had been screened and those who had not. Using data from the Swedish Cancer Registry and from the National Cervical Cancer Screening Registry, the researchers identified 1,230 cervical cancer patients who were diagnosed between 1999 and 2001, and 6,124 age-matched control subjects, from the population register, who had not been diagnosed with cervical cancer.

Women who had not had a Pap smear screening test within the recommended 3-year interval were 2.5 times as likely to be diagnosed with cervical cancer as women who had Pap tests regularly. These women were also nearly 5 times as likely to be diagnosed with advanced disease as those who were screened. Participation in screening reduced the risk for all types of cervical cancer and reduced the risk of women between twenty-three and thirty; these were both novel findings.

Screening did not completely protect women from cervical cancer diagnoses, however. Women who were screened within the recommended interval and
'/>"/>

Contact: Liz Savage
jncimedia@oxfordjournals.org
301-841-1287
Journal of the National Cancer Institute
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Systematic Review of Patient-Reported Outcomes (PROs) Can Reduce Cost of Cancer Care
2. SEIU RN Dian Palmer Calls on AFL-CIO Head John Sweeney to Review Video From Dearborn Protest, Retract Statement Accepting CNA Distortions
3. Review Urges Aggressive MRSA Screening for Health Workers
4. ACC Calls on FDA to Update Review of Bisphenol A
5. Press Preview to Unveil Miracle Manny
6. PreMD Provides Update on FDA Review
7. Neuroscience Peer Review Consortium announces increased journal participation
8. ExoSeal vascular plug gets good reviews in ECLIPSE study
9. Symmetry Medical Delays 10-K Filing to Complete Review
10. Review of group-based cancer trials reveals flaws in studies design and analysis
11. Ingenuity Systems Delivers Key Milestones in FDA Collaboration to Facilitate Genomic Data Review
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2008)...ng point for behavior change, DES MOINES, Iowa, O...,Americans (51 percent) believe there are good thi...r changes are needed, according to the 2008,EBRI H...oday by the,Employee Benefit Research Institute an...derwritten by the Principal Financial Group(R)., ...
(Date:10/10/2008)...dentialing Center (ANCC) has designated Geisinger ...s came via a conference call to hospital administr...and applause., GMC joins an elite group of only 1...n the United States that have achieved Magnet stat...s recognition., "Achieving Magnet designation is ...
(Date:10/10/2008)... blame , , FRIDAY, Oct. 10 (HealthDay Ne...ve diabetes, being depressed was associated with a..., Publishing in the October issue of the Journal...he University of Washington tracked 10,704 Medicar...d diabetes and were enrolled in a disease manageme...
(Date:10/10/2008)...llence in the implementation of electronic health ...agement Systems Society (HIMSS) announces the reci...onal, Ambulatory and Community Health Organization...L (PRWEB) October 10, 2008 -- Honoring excellence ... (EHRs), the Healthcare Information and Managemen...
Breaking Medicine News(10 mins):Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 2Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 3Health News:Geisinger Medical Center earns prestigious Magnet designation 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5
...versity of Pennsylvania report the first ever use ... multiple body organs.// Mucopolysaccharidosis VII... called lysosomal storage diseases. Other examples...PS involves an enzyme defect, leading to blindness...
...e new high-tech abortion drug being freely sold ov...f do-it-yourself-abortions,// experts fear. Alread...tives, they claim, and even as the pharmaceutical ...ar meals ostensibly to introduce them to “the revo...
...gh discovery, American researchers have found some...pond to stimuli in the womb. There have always bee...mens such as 'hothousing',// where the baby is rea...he womb. However, the effectiveness of inventions...
...emical Laboratory (NCL) and Emcure Pharmaceuticals...ith a new drug for the treatment of hypertension. ...sday,// NCL director Sivaram and Emcure managing d...odipine, a product of their collaborative research...
Other Medicine News:Health News:Abortion made easy pill causes alarm in state 2
(Date:10/9/2008)...ocuses on the need to protect the eyesight of,olde... 45 million people worldwide who,are blind, 80 per...ould,have avoided their blindness if they had been...imedia News Release, go to:, http://www.prnewswire... in eye care products and equipment, is,partnering...
(Date:10/9/2008)...- Diamyd Medical reports,th...he New England Journal,of Medicine, has published ...f the Diamyd(R) diabetes vaccine for type 1 diabet...20080314/297194 ), The article is now available ...and will be in print on October 30. It presents th...
(Date:10/8/2008)...e Pioneers Research That May Offer New Hope to,Hea... -- Nationally, over 3,000 people are,waiting for ...y, only half,of those will receive a transplant. N... (AHI) is paving the way for how to treat congesti...timedia News Release, go to:, http://www.prnewswir...
(Date:10/8/2008)... Potency of Poly-ICR as Vaccine Adjuvant, SAN DIE...rmaceuticals,Corporation (TSX: NVN) today presente... proprietary Toll-like Receptor 3 agonist, Poly IC...ngress 2008 in Lyon, France.,Study results demonst...geting the Toll-like Receptor 3 (TLR3) pathway. Da...
Breaking Medicine Technology:ORBIS and Alcon Call Attention to the Aging Eye 2ORBIS and Alcon Call Attention to the Aging Eye 3Diamyd(R) Study Published in Prestigious New England Journal of Medicine 2Diamyd(R) Study Published in Prestigious New England Journal of Medicine 3Diamyd(R) Study Published in Prestigious New England Journal of Medicine 4Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 2Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 2Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 4Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 5Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation 382 1Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation 382 2Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation 382 3Survival data presented from phase II study of hormone resistant prostate cancer patients 1991 1Survival data presented from phase II study of hormone resistant prostate cancer patients 1991 2Genes and environment grant funds close look at nature nurture overlap in common diseases 558 1Genes and environment grant funds close look at nature nurture overlap in common diseases 558 2Genes and environment grant funds close look at nature nurture overlap in common diseases 558 3New use for stem cells found in war on terrorism 556 1New use for stem cells found in war on terrorism 556 2New use for stem cells found in war on terrorism 556 3
0.5 mm, 1 x 2 teeth set at 45 degrees and 6 mm tying platform. Serrated handle with polished finish.
5 mm tying platform, serrated cross action handle with polished finish. Teeth: 0.10 mm, 1 x 2 set at 90 degrees.
Colibri style tips with 0.12 mm, 1 x 2 teeth. Round knurled handle with alignment pin and polished finish.
0.12 mm, 1 x 2 teeth set at 45 degrees with 6 mm tying platform. Wide serrated handle with polished finish.
Medicine Products: